152 related articles for article (PubMed ID: 37020869)
1. New prognostic system specific for epidermal growth factor receptor-mutated lung cancer brain metastasis.
Zhu LH; Fan XW; Sun L; Ni TT; Li YQ; Wu CY; Wu KL
Front Oncol; 2023; 13():1093084. PubMed ID: 37020869
[TBL] [Abstract][Full Text] [Related]
2. Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.
Li H; Lian J; Jin H; Wang W; Cao J; Zhang X; Song X; Jia S; Jia H; Ren J; Han S; Yang W; Xi Y; Lan S
J Neurooncol; 2017 May; 133(1):129-135. PubMed ID: 28391386
[TBL] [Abstract][Full Text] [Related]
3. Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases.
Li H; Lian J; Han S; Wang W; Jia H; Cao J; Zhang X; Song X; Jia S; Ren J; Yang W; Xi Y; Lan S
Oncotarget; 2017 Sep; 8(41):70727-70735. PubMed ID: 29050314
[TBL] [Abstract][Full Text] [Related]
4. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
5. Validation of a novel prognostic index: BMS-Score for patients with brain metastases of small cell lung cancer.
Hou R; Li H; Cao J; Song X; Zhang X; Wang W
Ann Palliat Med; 2021 Jan; 10(1):29-36. PubMed ID: 33440957
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
[No Abstract] [Full Text] [Related]
7. Concurrent brain radiotherapy and EGFR-TKI may improve intracranial metastases control in non-small cell lung cancer and have survival benefit in patients with low DS-GPA score.
Liu Y; Deng L; Zhou X; Gong Y; Xu Y; Zhou L; Wan J; Zou B; Wang Y; Zhu J; Ding Z; Peng F; Huang M; Ren L; Lautenschlaeger T; Kong FS; Lu Y
Oncotarget; 2017 Dec; 8(67):111309-111317. PubMed ID: 29340055
[TBL] [Abstract][Full Text] [Related]
8. Real-World Data on Prognostic Factors for Overall Survival in EGFR-Mutant Non-Small-Cell Lung Cancer Patients with Brain Metastases.
Yu X; Fan Y
J Cancer; 2019; 10(15):3486-3493. PubMed ID: 31293653
[No Abstract] [Full Text] [Related]
9. A nomogram for predicting brain metastases of EGFR-mutated lung adenocarcinoma patients and estimating the efficacy of therapeutic strategies.
Wang J; Zhang B; Pang Q; Zhang T; Chen X; Er P; Wang Y; You J; Wang P
J Thorac Dis; 2021 Feb; 13(2):883-892. PubMed ID: 33717561
[TBL] [Abstract][Full Text] [Related]
10. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
[TBL] [Abstract][Full Text] [Related]
11. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
[TBL] [Abstract][Full Text] [Related]
12. Exon 19 deletion of epidermal growth factor receptor is associated with prolonged survival in brain metastases from non-small-cell lung cancer.
Li H; Zhang X; Cao J; Su P; Lian J; Song X; Yang W; Han S; Xi Y; Wang Y
Tumour Biol; 2015 Dec; 36(12):9251-8. PubMed ID: 26091796
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract][Full Text] [Related]
14. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study.
Hou F; Hou Y; Sun XD; Lv J; Jiang HM; Zhang M; Liu C; Deng ZY
PeerJ; 2023; 11():e15678. PubMed ID: 37456882
[TBL] [Abstract][Full Text] [Related]
15. Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.
Luo J; Zhu H; Tang Y; Wang H; Zhou X; Lu X; Zhang S; Li Y
Int J Clin Exp Med; 2014; 7(12):5217-25. PubMed ID: 25664024
[TBL] [Abstract][Full Text] [Related]
16. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
17. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in patients with brain metastasis from non-small cell lung cancer treated with whole-brain radiotherapy.
Harada H; Asakura H; Ogawa H; Mori K; Takahashi T; Nakasu Y; Nishimura T
J Cancer Res Ther; 2016; 12(1):267-70. PubMed ID: 27072249
[TBL] [Abstract][Full Text] [Related]
19. Role of Recursive Partitioning Analysis and Graded Prognostic Assessment on Identifying Non-Small Cell Lung Cancer Patients with Brain Metastases Who May Benefit from Postradiation Systemic Therapy.
Liu S; Chen P; Liu YW; Gu XN; Qiu XG; Li B
Chin Med J (Engl); 2018 May; 131(10):1206-1213. PubMed ID: 29722340
[TBL] [Abstract][Full Text] [Related]
20. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
